HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 12, December 2019 – Precision Medicine for Brain Tumours       » First Alzheimer's drug to be approved in 17 years holds promise for treatment       » Tencent make medical information readily available to the public       » United States FDA approves first China-made cancer drug       » Value-Based Healthcare: A Paradigm Shift for Better Patient Outcomes       » Precision Agriculture for Future Nutritional Needs      
INSIDE INDUSTRY
Chugai, A*STAR research project to develop new virus antibody to fight against dengue
Project selected as US$4.4 million grant recipient by GHIT Fund

The fight against dengue continues with the latest joint research project between Chugai Pharmaceutical Co., Ltd. and the Agency for Science, Technology and Research, Singapore (A*STAR).

Dengue infects 390 million people annually and kills tens of thousands, with a recent study highlighting that nearly half the world鈥檚 population could be at risk of catching dengue by 2050.

In 2018 alone, a total of 3,285 dengue cases were reported in Singapore with five deaths by dengue last year. Dengue remains an endemic threat in Singapore and many developing countries.

This project seeks to create a new antibody drug against the dengue virus through the collaboration between Chugai Pharmabody Research, a research center of the Chugai Group in Singapore, and A*STAR鈥檚 Singapore Immunology Network (SIgN).

Through the support of the Global Health Innovative Technology Fund (GHIT Fund) with an approximately US$4.4 million grant, this project is set to combat the global burden of dengue and fight against neglected tropical diseases in developing countries.

Click here for the complete issue.

NEWS CRUNCH  
news Proteona awards grant to clinician-scientist for research in treatment selection of multiple myeloma
news Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
December:
Precision Medicine for Brain Tumours
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy